Suppr超能文献

神经纤维瘤病 1 型小鼠的运动缺陷:小脑的作用。

Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.

机构信息

Department of Neuroscience, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Genes Brain Behav. 2011 Jun;10(4):404-9. doi: 10.1111/j.1601-183X.2011.00685.x. Epub 2011 Mar 22.

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominantly inherited disease, characterized by various neurocutaneous symptoms, cognitive impairments and problems in fine and gross motor performance. Although cognitive deficits in NF1 have been attributed to increased release of the inhibitory neurotransmitter γ-amino butyric acid (GABA) in the hippocampus, the origin of the motor deficits is unknown. Cerebellar Purkinje cells, the sole output neurons of the cerebellar cortex, are GABAergic neurons and express neurofibromin at high levels, suggesting an important role for the cerebellum in the observed motor deficits in NF1. To test this, we determined the cerebellar contribution to motor problems in Nf1(+/-) mice, a validated mouse model for NF1. Using the Rotarod, a non-specific motor performance test, we confirmed that, like NF1 patients, Nf1(+/-) mice have motor deficits. Next, to evaluate the role of the cerebellum in these deficits, mice were subjected to cerebellum-specific motor performance and learning tests. Nf1(+/-) mice showed no impairment on the Erasmus ladder, as step time and number of missteps were not different. Furthermore, when compensatory eye movements were tested, no performance deficits were found in the optokinetic reflex and vestibulo-ocular reflex in the dark (VOR) or in the light (VVOR). Finally, Nf1(+/-) mice successfully completed short- and long-term VOR adaptation paradigms, tests that both depend on cerebellar function. Thus, despite the confirmed presence of motor performance problems in Nf1(+/-) mice, we found no indication of a cerebellar component. These results, combined with recent clinical data, suggest that cerebellar function is not overtly affected in NF1 patients.

摘要

神经纤维瘤病 1 型(NF1)是一种常染色体显性遗传疾病,其特征是存在各种神经皮肤症状、认知障碍以及精细和粗大运动表现问题。尽管 NF1 中的认知缺陷归因于海马中抑制性神经递质 γ-氨基丁酸(GABA)的释放增加,但运动缺陷的起源尚不清楚。小脑浦肯野细胞是小脑皮质的唯一输出神经元,是 GABA 能神经元,高水平表达神经纤维瘤蛋白,这表明小脑在 NF1 中观察到的运动缺陷中具有重要作用。为了验证这一点,我们确定了小脑对 Nf1(+/-) 小鼠(NF1 的一种有效小鼠模型)运动问题的贡献。使用转棒,一种非特异性运动表现测试,我们证实与 NF1 患者一样,Nf1(+/-) 小鼠存在运动缺陷。接下来,为了评估小脑在这些缺陷中的作用,对小鼠进行了小脑特异性运动表现和学习测试。Nf1(+/-) 小鼠在 Erasmus 阶梯上没有表现出障碍,因为步时和错误步数没有差异。此外,当测试代偿性眼球运动时,在暗(VOR)或亮(VVOR)条件下的视动反射和前庭眼反射中没有发现运动缺陷。最后,Nf1(+/-) 小鼠成功完成了短期和长期 VOR 适应范式测试,这些测试都依赖于小脑功能。因此,尽管在 Nf1(+/-) 小鼠中证实存在运动表现问题,但我们没有发现小脑成分的迹象。这些结果,结合最近的临床数据,表明小脑功能在 NF1 患者中没有明显受到影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验